Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published December 18, 2019

Medical Park Pharmacy Recalls Squaric Acid Topical Solution Due to Labeling Errors

Medical Park Pharmacy recalls Squaric Acid 0.1% Topical Solution due to incorrect labeling and use of expired components.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0816-2020DrugMedical Park Pharmacy ›
Take action

Contact the company

Recalling firmMPRX, Inc. dba Medical Park Pharmacy8230 Elmbrook Dr Ste 600b · Dallas, TX 75247-4144
✎ GovInfoNow plain-language explainer

Medical Park Pharmacy is recalling one bottle of Squaric Acid 0.1% Topical Solution (Clinic) because the product was compounded using expired components. The recall also addresses labeling issues, specifically that the lot and expiration date information may be incorrect or missing on some units. This affects products distributed in Texas. Read more at govinfonow.com/recall/37620-medical-park-pharmacy-recalls-squaric-acid-topical-solution-due-to.

Source Summary by GovInfoNow · govinfonow.com/recall/37620-medical-park-pharmacy-recalls-squaric-acid-topical-solution-due-to · Updated October 11, 2026 · FDA enforcement record: FDA #D-0816-2020

Cite this page

“Medical Park Pharmacy Recalls Squaric Acid Topical Solution Due to Labeling Errors.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/37620-medical-park-pharmacy-recalls-squaric-acid-topical-solution-due-to. Based on FDA recall #D-0816-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0816-2020%22&limit=1).

The FDA announced on Dec. 18, 2019, that MPRX, Inc. dba Medical Park Pharmacy voluntarily recalled Squaric Acid 0.1% Topical Solution (Clinic) 30 mL due to labeling errors and the use of expired components. The Class II recall affects products distributed in Texas.

How to tell if you have it

  • Brand: Medical Park Pharmacy
  • Product: Squaric Acid Topical Solution
  • Lot code: 61380:42
  • Use by date: 05/04/2020

The hazard

The product suffers from incorrect or missing lot and expiration dates on its label. Additionally, the records state that the products were compounded using expired components.

Context

GovInfoNow's records show other recent recalls of similar pharmaceutical products include American Regent Levocarnitine Injection Recall: Missing Label Hazard (2026-04-16) and Wells Pharma Fentanyl Citrate Injectable Solution Recall: Cgmp Deviations (2026-04-01). Another related recall listed is the Wells Pharma Fentanyl Citrate Solution Recall: CPG Deviations on 2026-04-01.

How to tell if you have this one

Check if you have a 30 mL bottle of Squaric Acid 0.1% Topical Solution (Clinic) manufactured by Medical Park Pharmacy. Look for lot number 61380:42 and a use-by date of 05/04/2020 on the label.

  • Brand
    Medical Park Pharmacy
  • Category
    Drug
FDA recall event · 18 products

All 18 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    TX
Recall numberProduct, codes & lotsQuantity
D-0803-2020DHEA/Pregnenol One 10.25 MG Cap; Lot: L61406:42 Use by: 05/06/20201 bottle
D-0804-2020Finasteride/Biotin 1 mg/50 mcg; Lot: 60658:42 Use by: 12/28/20191 bottle
D-0805-2020Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars; Lot: 61367:42 Use by: 04/28/20202 jars
D-0806-2020Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars; Lots: 61134:42 Use by: 01/31/2020; 61302:26 Use by: 04/14/2020; 61318:42 Use by: 04/19/202012 jars
D-0807-2020Liothyronine (T3) 80 mcg SR cap; Lot: 61253:42 Use by: 04/01/20205 bottles
D-0808-2020Liothyronine (T3) 92.5 MCG; Lot: 61024:99 Use by: 02/20/20204 bottles
D-0809-2020Magic Bullet Supplement; Lot: 61048:99 Use by: 02/08/20201 bottles
D-0810-2020Naltrexone 4.5 mg capsule; Lot: 60564:42 Use by: 02/10/20202 bottles
D-0811-2020Progesterone 200 mg Troche; Lot: 61242:26 Use by: 02/28/20201 bottle
D-0812-2020Progesterone 50 mg capsules; Lot: 61215:26 Use by: 03/23/20201 bottle
D-0813-2020Progesterone E4M SR 100 mg capsules; Lot: 61219:42 Use by: 03/24/20203 bottles
D-0814-2020Sildenafil 200 mg Troche (Clinic); Lot: 61392:42 Use by: 05/05/20201 bottle
D-0815-2020Sildenafil 80 mg capsules; Lot: 61404:42 Use by: 05/06/20201 bottle
D-0816-2020Squaric Acid 0.1% Topical Solution (Clinic) 30 mL; Lot: 61380:42 Use by: 05/04/20201 bottle
D-0817-2020T3/T4 SR 9 mcg/38 mcg capsule; Lot: 61296:42Use by: 04/13/20202 bottles
D-0818-2020Tadalafil 20 mg Troche; Lots: 61137:42 Use by: 03/08/2020; 61324:99 Use by: 04/04/2020; 60856:42 Use by: 02/02/20209 bottles
D-0819-2020Tadalafil 6 mg Capsule; Lots: 61229:26 Use by: 03/25/2020; 61229:42 Use by: 03/25/20207 bottles
D-0820-2020Testosterone Topical Cream 4%; Lot: 61463:42 Use by: 02/27/20203 bottles
Based on the official FDA remedy

What to do — step by step

  1. Contact the pharmacy

    Reach out to Medical Park Pharmacy directly for further instructions regarding this recall, as no specific remedy is listed in the record.

Where it went and when

Where it was distributed

Distributed in Texas.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Dec 18, 201912. FDA classified it Class II: Jan 29, 202023. Published in FDA’s Enforcement Report: Feb 5, 202034. FDA terminated the recall: Dec 13, 2022420192022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0816-2020 (December 18, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0816-2020 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA